Nieves López-Muñoz

5PUBLICATIONS
64CO-AUTHORS
Medical infection agents (incl. prions)Medical mycologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 01, 2025
Skin and Soft Tissue Mucormycosis in Patients Receiving Bruton Tyrosine Kinase Inhibitors: Case Report and Literature Review.

Eduardo Aparicio-Minguijón, Nieves López-Muñoz, Jorge Boán

|Nov 16, 2024
Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy.

Aintzane Zabaleta, Noemi Puig, Maria-Teresa Cedena

|Aug 07, 2024
Measurable residual disease (MRD) dynamics in multiple myeloma and the influence of clonal diversity analyzed by artificial intelligence.

J Martinez-Lopez, N Lopez-Muñoz, A Chari

|Mar 11, 2024
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.

Aina Oliver-Caldes, Marta Español-Rego, Aintzane Zabaleta

|Dec 18, 2023
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma.

Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente

Pageof 1

Frequent Collaborators

4 joint publications

Joaquín Martínez-López

2 joint publications

Lucía López-Corral

2 joint publications

Aintzane Zabaleta

2 joint publications

Manel Juan